Guillaume Goyette

Centre Hospitalier de l’Université de Montréal — Canada

Medicine · Health Sciences

30h-index4.4kcitations75works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(55), COVID-19 Clinical Research Studies(29), SARS-CoV-2 detection and testing(13), Viral gastroenteritis research and epidemiology(12), Long-Term Effects of COVID-19(8)

Publications71 total

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120
Cell chemical biology·2023· 26 citedOpen Access
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
Cell Reports Medicine·2023· 6 citedOpen Access
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Cell Reports·2023· 34 citedOpen Access
Publisher Correction: Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Nature Microbiology·2022· 7 citedOpen Access
Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
iScience·2022· 10 citedOpen Access
Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Nature Microbiology·2022· 226 citedOpen Access
HIV-1 Vpu restricts Fc-mediated effector functions in vivo
Cell Reports·2022· 29 citedOpen Access
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Cell Reports·2022· 27 citedOpen Access
Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
Viruses·2022· 15 citedOpen Access
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4 <sup>+</sup> T cell profile
2022Open Access
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
iScience·2022· 12 citedOpen Access
Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound
Journal of Virology·2022· 14 citedOpen Access
Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients
Kidney360·2022· 4 citedOpen Access
SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine
2022· 4 citedOpen Access
<scp>COVID</scp>‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia
Transfusion·2022· 4 citedOpen Access
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel
Journal of the Association of Medical Microbiology and Infectious Disease Canada·2022· 8 citedOpen Access
VE607 stabilizes SARS-CoV-2 Spike in the “RBD-up” conformation and inhibits viral entry
iScience·2022· 17 citedOpen Access
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Cell Reports·2022· 22 citedOpen Access
Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
2022· 2 citedOpen Access
Covid-19 vaccine immunogenicity in people living with HIV-1
Vaccine·2022· 78 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jonathan Richard(37), Andrés Finzi(37), Jérémie Prévost(31), Romain Gasser(26), Guillaume Beaudoin-Bussières(26), Halima Medjahed(26), Mehdi Benlarbi(24), Daniel E. Kaufmann(23), Shang Yu Gong(23), Alexandra Tauzin(22), Gabrielle Gendron‐Lepage(21), Catherine Bourassa(20), Annemarie Laumaea(17), Shilei Ding(17), Marceline Côté(17), Valérie Martel‐Laferrière(15), Dani Vézina(15), Marzena Pazgier(14), Walther Mothes(14), Renée Bazin(13)